FIRST-LINE GEFITINIB THERAPY FOR ELDERLY PATIENTS WITH NON-SMALL CELL LUNG CANCER HARBORING EGFR MUTATION: CENTRAL JAPAN LUNG STUDY GROUP 0901

被引：0

作者：

Takahashi, Kosuke ^{[1
]}

Saito, Hiroshi ^{[1
]}

Hasegawa, Yoshinori ^{[2
]}

Ando, Masahiko ^{[3
]}

Yamamoto, Masashi ^{[4
]}

Kojima, Eiji ^{[5
]}

Sugino, Yasuteru ^{[6
]}

Kimura, Tomoki ^{[7
]}

Yokoyama, Toshihiko ^{[8
]}

Ogasawara, Tomohiko ^{[9
]}

Shindoh, Joe ^{[10
]}

Yoshida, Norio ^{[11
]}

Suzuki, Ryujiro ^{[12
]}

机构：

[1] Aichi Hosp, Aichi Canc Ctr, Nagoya, Aichi, Japan

[2] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan

[3] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan

[4] Nagoya Ekisaikai Hosp, Nagoya, Aichi, Japan

[5] Komaki Municipal Hosp, Komaki, Japan

[6] Toyota Mem Hosp, Toyota, Aichi, Japan

[7] Tosei Genaral Hosp, Seto, Aichi, Japan

[8] Japanese Red Cross Nagoya Daiichi Hosp, Nagoya, Aichi, Japan

[9] Japanese Red Cross Nagoya Daini Hosp, Nagoya, Aichi, Japan

[10] Ogaki Municipal Hosp, Dept Resp Med, Ogaki, Japan

[11] Kariya Toyota Gen Hosp, Kariya, Aichi, Japan

[12] Toyohashi Municipal Hosp, Toyohashi, Aichi, Japan

来源：

关键词：

non-small cell lung cancer; EGFR mutation; gefitinib; elderly;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1.11-017

引用

页码：S601 / S601

页数：1